Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-21

Clinical Trial Update: Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing S-1 + cisplatin versus cisplatin alone in cervical cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Cervical Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-06-21